Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection

Journal of Surgical Oncology

Volumn 102, Issue 2, 2010, Pages 111-118

  Ashikaga, Takamaru ^a   Krag, David N ^a   Land, Stephanie R ^b,c   Julian, Thomas B ^b,c   Anderson, Stewart J ^c   Brown, Ann M ^c   Skelly, Joan M ^a   Harlow, Seth P ^a   Weaver, Donald L ^a   Mamounas, Eleftherios P ^d   Costantino, Joseph P ^c   Wolmark, Norman ^b,e  

^a UNIVERSITY OF VERMONT   (United States)

^b NSABP Foundation Inc   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d Aultman Health Foundation   (United States)

^e ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Arm swelling; Numbness; Shoulder abduction; Tingling

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HAND PARESTHESIA; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TUMOR VOLUME;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPESTHESIA; LYMPH NODE EXCISION; LYMPHEDEMA; MIDDLE AGED; PARESTHESIA; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; SHOULDER JOINT;

EID: 77955112278     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21535     Document Type: Article

References (14)

1. Gill G: Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial. Ann Surg Oncol 2009;16:266-275.
2. Del Bianco P, Zavagno G, Burelli P, et al.: Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008;34:508-513. (Pubitemid 351514885)
3. Mansel RE, Fallowfield L, Kissin M, et al.: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609. (Pubitemid 43904843)
4. Fleissig A, Fallowfield LJ, Langridge CI, et al.: Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-293.
5. Purushotham AD, Upponi S, Klevesath MB, et al.: Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 2005;23:4312-4321.
6. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553. (Pubitemid 36951366)
7. Krag DN, Julian TB, Harlow SP, et al.: NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial. Ann Surg Oncol 2004;11:208S-210S.
8. Krag DN, Anderson SJ, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-888.
9. SAS (Ver 9) SAS Institute Inc., Cary, North Carolina 27511.
10. SYSTAT (Ver 11) SYSTAT Software Inc., Richmond, CA 94804.
11. StatXact (Ver 4) Cytel Software Corporation, Cambridge, MA 02139.
12. Luttgens K, Hamilton N: Kinesiology: Scientific basis of human motion, 9th edition. Madison, WI: Brown & Benchmark; 1997.
13. Kligman L, Wong R, Johnston M, et al.: The Treatment of Lymphedema Related to Breast Cancer-Evidence Summary Report #13-1. August 22, 2003. Cancer Care Ontario. http://www.cancercare.on.ca/pdf/pebces13-1f.pdf. Accessed May 7, 2009.
14. Tsai RJ, Dennis LK, Lynch CF, et al.: The risk of developing arm lymphedema among breast cancer survivors: A meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959-1972.